Clinical evaluation of TEG6s PlateletMapping assay during cardiopulmonary bypass : A prospective observational study

Clinical evaluation of TEG6s PlateletMapping assay during cardiopulmonary bypass : A prospective observational study - Clinical evaluation of TEG6s PlateletMapping assay during cardiopulmonary bypass.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034731

Enrollment

Registered

2018-12-01

Start date

2019-03-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

1. Patients undergoing cardiovascular surgery using cardiopulmonary bypass

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient undergoing an elective cardiovascular surgery using cardiopulmonary bypass in Tokyo Medical and Dental University

Exclusion criteria

Exclusion criteria: Patients who refuse obtainment of informed consent

Design outcomes

Primary

Measure	Time frame
1.Correlation between plasma fibrinogen concentration and MAFibrin in Platelet Mapping assay. 2.Correlation between platelet count and MAADP, MAThrombin	—

Secondary

Measure	Time frame
1) Correlation between platelet inhibition (MAThrombin - MAADP) and medication history, duration of cardiopulmonary bypass 2) Comparing the data from the samples drawn at the end of the aortic cross clamping with those from the samples drawn after protamine administration	—

Countries

Japan

Contacts

Public ContactYudai Yamamoto

Tokyo Medical and Dental University Graduate School of Medicine Department of Anesthesiology

pocanalysis-group@umin.ac.jp03-5803-5325

Outcome results